Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus

Abstract Background Zika virus (ZIKV) infection is a global health problem, and its complications, including congenital Zika syndrome and Guillain-Barré syndrome, constitute a continued threat to humans. Unfortunately, effective therapeutics against ZIKV infection are not available thus far. Methods...

全面介绍

书目详细资料

Principais autores:	Jie Yuan, Jianchen Yu, Yun Huang, Zhenjian He, Jia Luo, Yun Wu, Yingchun Zheng, Jueheng Wu, Xun Zhu, Haihe Wang, Mengfeng Li
格式:	Artigo
语言:	Inglês
出版:	BMC 2020-07-01
丛编:	BMC Medicine
主题:	Zika virus Fidaxomicin RdRp inhibitor NS5 Antiviral
在线阅读:	http://link.springer.com/article/10.1186/s12916-020-01663-1
标签:	添加标签 没有标签, 成为第一个标记此记录!